C14H 12 BrNO 3 , triclinic, P1 (no. 2), a = 8.4134(5) Å, b = 9.5365(6) Å, c = 9.6154(7) Å, α = 60.728(2)°, β = 83.130(2)°, γ = 66.331(2)°, V = 613.52(7) Å 3 , Z = 2, Rgt(F) = 0.0393,
easily synthesized in accord with a known patent [3] . Evaporation at room temperature yielded colorless crystals of 7-bromo-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylic acid.
Experimental details
The hydrogen atoms were placed on calculated positions with the help of the SHELX program (AFIX 43, 0, 13, 23 or 137 option). All H atoms were positioned geometrically and refined using a riding model: O-H = 0.87 Å, C-H = 0.93 and 0.96 Å for aromatic and CH 3 H atoms, respectively, with U iso (H) = k × Ueq (N,C) , where k = 1.5 for CH 3 H atoms and = 1.2 for other H atoms.
Discussion
The title compound, we report here, is an important intermediate of the ozenoxacin synthesis. Ozenoxacin is an experimental quinolone antibiotic being developed for the treatment of impetigo and other dermatological bacterial infections. Now ozenoxacin has been approved in USA by FDA for the topical treatment of impetigo. Ozenoxacin is active against some bacteria that have developed resistance to currently used quinolone and fluoroquinolone antibiotics. The molecular structure of the title compound is shown in the figure, the bond lengths and angles are within normal ranges [4] .
The crystal structure analysis of the title compound revealed that there are three rings, ring A (C4-C5-C6-C7-C8-C9), ring B (N1-C1-C2-C3-C4-C5) and ring C (C10-C11-C12). The dihedral angles between ring A and ring B is 8.8(2)°. The dihedral angles between the ring A and ring C is 82.3(3)°. The dihedral angles between the ring C and ring B is 74.4(2)°. In the crystal of the title compound there is one O-H· · · O intramolecular hydrogen bond (cf. the figure) . Meanwhile, molecules are linked by C-H· · · O intermolecular hydrogen bonds to form a two-dimensional network.
